These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2741)

  • 21. [Effect of temperature on the kinetics of propranolol, theophylline, phenytoin and digoxin in rats (author's transl)].
    Albin H; Vincon G; Ploux D; Dangoumau J
    J Pharmacol; 1981; 12(3):229-38. PubMed ID: 7289622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The disposition of propranolol. VII. The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver.
    Shand DG; Branch RA; Evans GH; Nies AS; Wilkinson GR
    Drug Metab Dispos; 1973; 1(5):679-86. PubMed ID: 4149706
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical pharmacokinetics of some antiarrhythmic drugs.
    Ochs HR; Greenblatt DJ; Bodem G
    Herz; 1979 Aug; 4(4):330-43. PubMed ID: 391683
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of practolol in the rabbit with experimental glomerulonephritis.
    Harvengt C; Desager JP; Vanderbist M
    Pharmacology; 1975; 13(6):533-8. PubMed ID: 1221435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM; Kumana CR; Franklin DA; Baker LR
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of oral neomycin on the absorption of isoniazid, quinidine and sulphafurazole from the rat small intestine in situ.
    Venho VM; Koivuniemi A
    Arzneimittelforschung; 1982; 32(2):141-3. PubMed ID: 7199917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition.
    Lo MW; Effeney DJ; Pond SM; Silber BM; Riegelman S
    J Pharmacol Exp Ther; 1982 May; 221(2):512-5. PubMed ID: 7077541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The evaluation criterions about Caco-2 cell model].
    Ma Y; Li PB; Su WW; Chen DW
    Zhong Yao Cai; 2006 Sep; 29(9):946-8. PubMed ID: 17212055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The distribution and irreversible tissue binding of practolol and its metabolites in the hamster [proceedings].
    Lindup WE; Longshaw S; Orton TC; Whittaker SE
    Br J Pharmacol; 1979 Jul; 66(3):504P. PubMed ID: 526773
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetics of propranolol, the beta-adrenergic receptor blocking agents (author's transl)].
    Lou YQ
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):167-70. PubMed ID: 7313673
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):295-301. PubMed ID: 6631714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat.
    Dahan A; West BT; Amidon GL
    Eur J Pharm Sci; 2009 Feb; 36(2-3):320-9. PubMed ID: 19028572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
    Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
    J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption, elimination and duration of action of diethyldithiocarbamate in animals [proceedings].
    Craven MR; Luscombe DK; Nicholls PJ
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():38P. PubMed ID: 12313
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of ageing on drug absorption from the gut.
    Castleden CM; Volans CN; Raymond K
    Age Ageing; 1977 Aug; 6(3):138-43. PubMed ID: 899963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
    González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
    Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dosage of digitalis glycosides and beta blockers in renal insufficiency].
    Ohnhaus EE
    Med Klin; 1976 Oct; 71(44):1867-72. PubMed ID: 11399
    [No Abstract]   [Full Text] [Related]  

  • 38. Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings).
    Orton TC; Lowery C; Lindup WE
    Br J Pharmacol; 1977 Jun; 60(2):319P. PubMed ID: 880481
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of salt form and concentration on the absorption of magnesium in rat small intestine.
    Dolinska B; Ryszka F
    Boll Chim Farm; 2004 May; 143(4):163-5. PubMed ID: 15255338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption kinetics of sublingually administered propranolol.
    Kates RE
    J Med; 1977; 8(6):393-402. PubMed ID: 272433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.